Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: biotechnology law
Divided We Fall – New Rules Limit Divisional Applications in Australia
This is a guest post from Bill Bennett of Pizzeys. Where a divisional application presents claims for examination which have been previously rejected in the parent (or grand-parent) application, then the APO will give the applicant only 2 months to … Continue reading
UK Patent Applications On The Fast Track – Nothing Extra Payable
Guest post from Paul Cole of Lucas & Co. Claims searched, examined and approved for grant (subject to publication and possible third party comments) within six working days? Not only theoretically possible but actually achieved in an application filed earlier … Continue reading
Posted in Non-U.S. Practice
Tagged biotechnology, biotechnology law, CSE, EPO, fast track, intellectual property, ip, IP law tools, Paul Cole, PCT application, UK IP
Leave a comment
Get Your Application On The Fast Track – For A Price
On Friday, the PTO proposed changes in the rules to permit applicants for U.S. patents to receive “prioritized examination” (76 Fed. Reg. 6370 (Feb. 4 2011) – a copy is attached below). This program is a remnant of the three-track … Continue reading
ACLU Files Its Brief in Myriad – Argues DNA Is A Blueprint Without a Name
On November 30, 2010, the ACLU filed its brief at the Federal Circuit in AMP et al. v. USPTO and Myriad Genetics, Inc. et al. If you have been reading my posts on this suit, you are by now probably … Continue reading